Exudate Macrophages Attenuate Lung Injury by the Release of IL-1 Receptor Antagonist in Gram-negative Pneumonia
Susanne Herold(Justus-Liebig-Universität Gießen), Juergen Lohmeyer(Justus-Liebig-Universität Gießen), Maciej Cabanski, Tannaz Shafiei Tabar, Frank Driever(Universities of Giessen and Marburg Lung Center), Mirko Steinmueller(Justus-Liebig-Universität Gießen), Katrin Hoegner, Hermann Janßen(John Deere (Germany)), Jens Albrecht(Georg Simon Ohm University of Applied Sciences Nuremberg), Werner Seeger(Justus-Liebig-Universität Gießen), Peter Lewe-Schlosser(German Center for Lung Research), István Vadász(Northwestern University)
American Journal of Respiratory and Critical Care Medicine
January 29, 2011
Cited by 108
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
|The Lancet|2002|771
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683